Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.

Fifty-one patients with advanced non-small cell lung carcinoma were treated with a combination of mitomycin C, vinblastine and cis-platin (MVP). Most cycles were given on an out-patient basis. Major side effects were leukopenia and peripheral neurotoxicity; one patient died of sepsis while leukopeni...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Giaccone, G., Bagatella, M., Donadio, M., Bonardi, G. M., Testore, F., Ferrati, P., Ciuffreda, L., Calciati, A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1987
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001818/
https://ncbi.nlm.nih.gov/pubmed/2825750
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky